INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

71,130 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
Thomas H. Kean, Jr.RSelf
JNJJOHNSON & JOHNSON
Partial sale
SELL$1,001 – $15KSep 30, 2026
Page 141 of 1779
← PrevNext →
Oct 30, 2026
traded Sep 30, 2026
+30d
House PTR

Evidence

15
MS
McClain SeanDirector, Chief Executive Officer
ABSIAbsci Corp
Tax withholding
F$966K
79.9K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

14
LL
Livschitz LeonardDirector, CHIEF EXECUTIVE OFFICER
GDYNGRID DYNAMICS HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$120K
10.0K sh
Oct 30, 2026Oct 30, 2026
traded Oct 30, 2026
+0dSEC Form 4

Evidence

14
TD
Taylor Ryan D.See Remarks
PLTRPalantir Technologies Inc.
Grant or award
A—
211.2K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

14
SS
Sankar ShyamSee Remarks
PLTRPalantir Technologies Inc.
Grant or award
A—
564.8K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

14
AO
Atay OguzhanDirector, Chairman and CEO
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$315K
2,667 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

14
GY
Gryzlov YuryCHIEF OPERATING OFFICER
GDYNGRID DYNAMICS HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$110K
10.5K sh
Oct 30, 2026Oct 30, 2026
traded Oct 30, 2026
+0dSEC Form 4

Evidence

14
VE
Venker EricPresident & Immunovant CEO
ROIVRoivant Sciences Ltd.
Open-market sale · 10b5-1 plan
SELL$7.32M
200.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

14
LR
Lewis Michelle ReneeChief Accounting Officer
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$118K
2,364 sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

13
WM
Wunsch Scott MCEO, Logistics
SRTAStrata Critical Medical, Inc.
Grant or award
A—
57.2K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

13
JW
Juvenal Tobin WChief Commercial Officer
CSTLCASTLE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$196K
5,341 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

13
PB
PAEPER HOLLY BethDirector
LFUSLITTELFUSE INC /DE
Grant or award
A$25K
62 sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

13
SF
Siegfried Erin FreundChief Legal Counsel /Corp Sec
NWBINorthwest Bancshares, Inc.
Tax withholding
F$26K
1,708 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

13
CW
Charters WilliamDirector
RGSREGIS CORP
Grant or award
A—
2,857 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

13
WM
Wunsch Scott MCEO, Logistics
SRTAStrata Critical Medical, Inc.
Grant or award
A—
57.2K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

13
HA
Hardy AndrewEVP, Chief Sales Officer
NXPINXP Semiconductors N.V.
Option exercise
M—
1,080 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

13
SJ
Scheiwer Mark JEVP, CFO & CAO
SMGSCOTTS MIRACLE-GRO CO
Grant or award
A—
2,163 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

13
RE
Ronald Ivan EdwardChief Financial Officer
ANNAAleAnna, Inc.
Option exercise
M—
13.3K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

13
VP
Valenzuela Rionda Jose PedroDirector
SCCOSOUTHERN COPPER CORP/
Grant or award
A—
400 sh
Oct 30, 2026Oct 30, 2026
traded Oct 30, 2026
+0dSEC Form 4

Evidence

13
VG
vant Hoff GrahamDirector
ANNAAleAnna, Inc.
Option exercise
M—
20.2K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

13
AJ
Arrigunaga Gomez del Campo JavierDirector
SCCOSOUTHERN COPPER CORP/
Grant or award
A—
400 sh
Oct 30, 2026Oct 30, 2026
traded Oct 30, 2026
+0dSEC Form 4

Evidence

12
GA
Grimme ArneDirector
NBISNebius Group N.V.
Open-market purchase · 10b5-1 plan
BUY$25K
148 sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

12
SD
Sanders DaxPresident
KMIKINDER MORGAN, INC.
Gift
G—
1,600 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

12
BW
Betz WilliamEVP & CFO
NXPINXP Semiconductors N.V.
Tax withholding
F$107K
423 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

12
HA
Hardy AndrewEVP, Chief Sales Officer
NXPINXP Semiconductors N.V.
Tax withholding
F$139K
550 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

11
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$95K
1,904 sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

11
HM
Hancock MarkDirector, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$214K
4,280 sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

10
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$241K
7,500 sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

10
GA
Glazer David A.See Remarks
PLTRPalantir Technologies Inc.
Grant or award
A—
211.2K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
65.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
WL
West Michael LCEO - Moody's Ratings
MCOMOODYS CORP /DE/
Option exercise
M—
6,820 sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
KA
Kritzmacher John ADirector
IDCCInterDigital, Inc.
Grant or award
A—
2 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
VG
vant Hoff GrahamDirector
ANNAAleAnna, Inc.
Option exercise
M—
20.2K sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
195.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
82.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
CP
Carey Stephen P.SVP & CFO
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$208K
2,850 sh
Oct 29, 2026Oct 30, 2026
traded Oct 29, 2026
+1dSEC Form 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
48.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
WM
Wunsch Scott MCEO, Logistics
SRTAStrata Critical Medical, Inc.
Grant or award
A—
1,416 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
269.3K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence

9
HD
Hutcheson Stewart DDirector
IDCCInterDigital, Inc.
Grant or award
A—
47 sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC Form 4

Evidence